Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
BACKGROUND
The interferon (IFN)-induced, dsRNA-dependent serine/threonine protein kinase, PKR, plays a key regulatory role in the IFN-mediated anti-viral response by blocking translation in the infected cell by phosphorylating the alpha subunit of elongation factor 2 (eIF2). The human immunodeficiency virus type 1 (HIV-1) evades the anti-viral IFN response through the binding of one of its major transcriptional regulatory proteins, Tat, to PKR. HIV-1 Tat acts as a substrate homologue for the enzyme, competing with eIF2alpha, and inhibiting the translational block. It has been shown that during the interaction with PKR, Tat becomes phosphorylated at three residues: serine 62, threonine 64 and serine 68. We have investigated the effect of this phosphorylation on the function of Tat in viral transcription. HIV-1 Tat activates transcription elongation by first binding to TAR RNA, a stem-loop structure found at the 5' end of all viral transcripts. Our results showed faster, greater and stronger binding of Tat to TAR RNA after phosphorylation by PKR.


RESULTS
We have investigated the effect of phosphorylation on Tat-mediated transactivation. Our results showed faster, greater and stronger binding of Tat to TAR RNA after phosphorylation by PKR. In vitro phosphorylation experiments with a series of bacterial expression constructs carrying the wild-type tat gene or mutants of the gene with alanine substitutions at one, two, or all three of the serine/threonine PKR phosphorylation sites, showed that these were subject to different levels of phosphorylation by PKR and displayed distinct kinetic behaviour. These results also suggested a cooperative role for the phosphorylation of S68 in conjunction with S62 and T64. We examined the effect of phosphorylation on Tat-mediated transactivation of the HIV-1 LTR in vivo with a series of analogous mammalian expression constructs. Co-transfection experiments showed a gradual reduction in transactivation as the number of mutated phosphorylation sites increased, and a 4-fold decrease in LTR transactivation with the Tat triple mutant that could not be phosphorylated by PKR. Furthermore, the transfection data also suggested that the presence of S68 is necessary for optimal Tat-mediated transactivation.


CONCLUSIONS
These results support the hypothesis that phosphorylation of Tat may be important for its function in HIV-1 LTR transactivation.
Endo-Munoz
Liliana
L
Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia. lmunoz@cicr.uq.edu.au
Warby
Tammra
T
Harrich
David
D
McMillan
Nigel A J
NA
D000595:Amino Acid Sequence; D015971:Gene Expression Regulation, Enzymologic; D015967:Gene Expression Regulation, Viral; D015696:Gene Products, tat / Q000378:metabolism*; D016325:HIV Long Terminal Repeat / Q000502:physiology*; D015497:HIV-1 / Q000235:genetics / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D010766:Phosphorylation; D011485:Protein Binding; D012367:RNA, Viral / Q000378:metabolism; D019892:eIF-2 Kinase / Q000378:metabolism*; D054322:tat Gene Products, Human Immunodeficiency Virus
D015696:Gene Products, tat; D012367:RNA, Viral; D054322:tat Gene Products, Human Immunodeficiency Virus; D019892:eIF-2 Kinase
Cell. 1977 May;11(1):187-200
559547
Science. 1999 Jul 2;285(5424):107-10
10390359
Science. 1984 May 4;224(4648):500-3
6200936
J Infect Dis. 1985 Sep;152(3):466-72
2411826
Prog Clin Biol Res. 1985;202:405-13
3008172
Cell. 1986 Sep 26;46(7):973-82
3530501
Cell. 1987 Feb 27;48(4):691-701
3643816
EMBO J. 1987 Mar;6(3):689-97
3582371
Virology. 1987 Jul;159(1):126-36
2440179
Nature. 1987 Dec 3-9;330(6147):489-93
2825027
Nature. 1988 Jul 14;334(6178):165-7
3386755
Proc Natl Acad Sci U S A. 1988 Nov;85(21):7887-91
2460857
AIDS Res Hum Retroviruses. 1988 Aug;4(4):287-94
3144996
J Virol. 1989 May;63(5):2244-51
2539516
Genes Dev. 1989 Apr;3(4):547-58
2470647
Cell. 1989 Oct 20;59(2):273-82
2478293
Science. 1990 Mar 9;247(4947):1216-9
2180064
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5817-21
1696012
Nucleic Acids Res. 1991 Jan 25;19(2):243-8
1673026
J Virol. 2000 Dec;74(23):11215-21
11070019
Biochemistry. 2002 May 21;41(20):6391-7
12009901
Virology. 2002 Apr 25;296(1):6-16
12036313
Microbiol Immunol. 2002;46(11):787-99
12516777
Proc Natl Acad Sci U S A. 1991 May 1;88(9):4045-9
2023953
Mol Cell Biol. 1991 Jul;11(7):3652-9
2046671
EMBO J. 1991 Dec;10(13):4189-96
1756726
AIDS Res Hum Retroviruses. 1992 Feb;8(2):199-207
1371692
J Virol. 1993 Mar;67(3):1688-92
8094759
J Virol. 1993 Jul;67(7):3703-11
8389901
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4278-82
7514301
Virology. 1994 Jul;202(1):186-94
7516596
Virology. 1995 Nov 10;213(2):413-24
7491766
Virology. 1996 May 1;219(1):321-3
8623549
Arch Biochem Biophys. 1996 Nov 1;335(1):8-12
8914829
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
9023344
J Biol Chem. 1997 Mar 28;272(13):8388-95
9079663
Biochemistry. 1997 Oct 28;36(43):13256-62
9341215
Cell. 1998 Feb 20;92(4):451-62
9491887
Biochemistry. 1998 Mar 17;37(11):3795-809
9521699
Mol Cell Biol. 1998 Sep;18(9):5208-18
9710605
J Virol. 1998 Nov;72(11):8620-6
9765401
Science. 1983 May 20;220(4599):868-71
6189183